Why is TRVI Up Today?
About Trevi Therapeutics, Inc. Common Stock
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indicatio...
Overall Confidence: 75%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: +0.6%
Market Comparison
🔔 Get TRVI Alerts
We'll notify you when TRVI's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
TRVI has moved more than 3.0% up on 52 occasions in the past year.
Frequently Asked Questions
Why is TRVI stock up today?
Options traders are heavily buying calls on TRVI, with 74% of volume in calls. This suggests bullish institutional positioning.
Is TRVI stock a buy or sell right now?
Based on current analysis, TRVI shows 75% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the TRVI stock price target?
TRVI is currently trading at $16.39. Based on today's momentum, the expected short-term range is $16.06 - $16.88. See long-term price prediction →
Will TRVI stock continue rising?
Our analysis shows a 45% probability that TRVI's move continues in the next 1-3 days. Key level to watch: $17.21 (resistance).
Is TRVI stock oversold or overbought?
TRVI's RSI (Relative Strength Index) is currently at 33.4. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for TRVI stock?
TRVI's 10-day momentum indicator is at -2.06. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is TRVI outperforming or underperforming the market?
TRVI (+3.02%) is currently significantly outperforming the market (+2.2% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.
What does MACD indicate for TRVI?
TRVI's MACD (-0.43) is currently below the signal line (-0.24), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 21.9) is moderate.
Is TRVI in an uptrend or downtrend?
Based on moving average analysis, TRVI is in a bearish trend. The price ($16.39) is trading below both the 20-day SMA ($17.47) and 50-day SMA ($17.81). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis